JPM, Vol. 15, Pages 372: Functional Mitral Regurgitation in the Transcatheter Era: Diagnostic and Therapeutic Pathways
Journal of Personalized Medicine doi: 10.3390/jpm15080372
Authors:
Francesca Maria Di Muro
Luigi Spadafora
Angela Buonpane
Francesco Leuzzi
Giulia Nardi
Eduardo Bossone
Giuseppe Biondi Zoccai
Tiziana Attisano
Francesco Meucci
Carlo Di Mario
Carmine Vecchione
Gennaro Galasso
Functional mitral regurgitation (FMR) is a common condition with significant prognostic implications, primarily driven by left atrial or ventricular remodeling secondary to ischemic or non-ischemic cardiomyopathies. While guideline-directed medical therapy (GDMT) remains the cornerstone of management, reducing mitral regurgitation severity in up to 40–45% of cases, additional interventions are often necessary. In patients where atrial fibrillation (AF) or ventricular dyssynchrony due to abnormal electrical conduction contributes to disease progression, guideline-directed AF management or cardiac resynchronization therapy plays a pivotal role. For those with persistent moderate to severe MR and unresolved symptoms despite optimal GDMT, percutaneous intervention may be warranted, provided specific clinical and echocardiographic criteria are met. This review highlights a precision-medicine approach to patient selection for transcatheter treatment of functional mitral regurgitation (FMR), emphasizing the integration of clinical characteristics with advanced multimodal imaging, including echocardiography, cardiac magnetic resonance, and computed tomography. In anatomically or clinically complex cases, complementary use of these imaging modalities is essential to ensure accurate phenotyping and procedural planning. Once a suitable candidate for percutaneous intervention has been identified, we provide a detailed overview of current transcatheter strategies, with a focus on device selection tailored to anatomical and pathophysiological features. Finally, we discuss emerging technologies and evolving therapeutic paradigms that are shaping the future of individualized FMR management.
Source link
Francesca Maria Di Muro www.mdpi.com
